跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Levipil - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Levipil
Approved
STANDARD
Levipil
Sun Pharmaceutical Medicare Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
17a2cb20dba30003
Company
Sun Pharmaceutical Medicare Limited
Type
Standard
Approval Details
Approval Id
17a2cb20dba30003
Drug Approval Philippines Name
Levipil
Product Name
Levipil
Registration Number
DRP-11418
Brand Name
Levipil
Generic Name
Levetiracetam
Dosage Form
Concentrate Solution for IV Infusion
Dosage Strength
100 mg/mL
Manufacturer
Sun Pharmaceutical Medicare Limited
Importer
Sun Pharma Philippines, Inc.
Distributor
Sun Pharma Philippines, Inc.
Company Detail Path
/organization/sun-pharmaceutical-medicare-limited
Issuance Date
04 June 2024
Expiry Date
09 May 2028
Pharmacologic Category
Antiepileptic
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
17a2cb20dba30003
Type
Standard
Back to Philippines FDA Approvals